Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.
2.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
3.
4.

Obstacles to successful antiretroviral treatment of HIV-1 infection: problems & perspectives.

Potter SJ, Chew CB, Steain M, Dwyer DE, Saksena NK.

Indian J Med Res. 2004 Jun;119(6):217-37. Review.

PMID:
15243161
5.

Understanding the guidelines for treating HIV disease.

Chesebro MJ, Everett WD.

Am Fam Physician. 1998 Jan 15;57(2):315-22, 328. Review. Erratum in: Am Fam Physician 1998 Jun;57(11):2630.

6.

Standard care impact on effects of highly active antiretroviral therapy adherence interventions: A meta-analysis of randomized controlled trials.

de Bruin M, Viechtbauer W, Schaalma HP, Kok G, Abraham C, Hospers HJ.

Arch Intern Med. 2010 Feb 8;170(3):240-50. doi: 10.1001/archinternmed.2009.536. Review.

PMID:
20142568
7.

Boosted protease inhibitors as a therapeutic option in the treatment of HIV-infected children.

Ramos J.

HIV Med. 2009 Oct;10(9):536-47. doi: 10.1111/j.1468-1293.2009.00728.x. Review.

8.

[Anti-retroviral treatment of HIV infection in the child].

De José Gómez MI.

Allergol Immunopathol (Madr). 1998 May-Jun;26(3):139-44. Review. Spanish.

PMID:
9675397
9.

[AIDS: new developments. VI. HIV reservoirs during intensive antiretroviral treatment].

Notermans DW, Danner SA, de Wolf F, Lange JM.

Ned Tijdschr Geneeskd. 1998 Aug 22;142(34):1909-12. Review. Dutch.

PMID:
9856176
10.

Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS.

Haddad M, Inch C, Glazier RH, Wilkins AL, Urbshott G, Bayoumi A, Rourke S.

Cochrane Database Syst Rev. 2000;(3):CD001442. Review. Update in: Cochrane Database Syst Rev. 2006;(3):CD001442.

PMID:
10908497
11.

[Antiretroviral therapy in children].

Jakob-Sölder B.

Wien Med Wochenschr. 1998;148(23-24):539-46. Review. German.

PMID:
10189683
12.

Can community health workers improve adherence to highly active antiretroviral therapy in the USA? A review of the literature.

Kenya S, Chida N, Symes S, Shor-Posner G.

HIV Med. 2011 Oct;12(9):525-34. doi: 10.1111/j.1468-1293.2011.00921.x. Epub 2011 Apr 24. Review.

13.

[Salvage therapy in HIV disease].

Ajisawa A.

Nihon Rinsho. 2002 Apr;60(4):745-9. Review. Japanese.

PMID:
11968782
14.

Modern anti-HIV therapy.

Flepp M, Schiffer V, Weber R, Hirschel B.

Swiss Med Wkly. 2001 Apr 21;131(15-16):207-13. Review.

PMID:
11400543
15.

Bridging the gap. Bringing new antiretroviral medications into the clinic.

Williams A.

Adv Nurse Pract. 1999 Jan;7(1):24-30; quiz 31-2. Review.

PMID:
10030167
16.

[Antiretroviral therapy in childhood].

Feiterna-Sperling C.

Zentralbl Gynakol. 1999;121(1):35-6. Review. German.

PMID:
10091313
17.

HIV therapeutic possibilities of gold compounds.

Fonteh PN, Keter FK, Meyer D.

Biometals. 2010 Apr;23(2):185-96. doi: 10.1007/s10534-010-9293-5. Epub 2010 Feb 3. Review.

PMID:
20127392
19.

Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities.

Nachega JB, Mills EJ, Schechter M.

Curr Opin HIV AIDS. 2010 Jan;5(1):70-7. doi: 10.1097/COH.0b013e328333ad61. Review.

PMID:
20046150
20.

Determinants of the natural history of human immunodeficiency virus type 1 infection.

Phair JP.

J Infect Dis. 1999 Mar;179 Suppl 2:S384-6. Review.

PMID:
10081512

Supplemental Content

Support Center